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Case Report
Unusual Presentations of Wegener’s Granulomatosis:
Pitfalls in Early Diagnosis
Syed Mansoor Ahmed Shah, Malik Anas Rabbani, Ambreen Gul, Aasim Ahmad
Department of Medicine, Aga Khan University Hospital, Karachi
ABSTRACT. Wegener’s Granulomatosis (WG) is a disorder characterized by necrotizing
granulomatous vasculitis that primarily affects the upper and lower respiratory tracts and
the kidneys. Although the cause is unknown, there is strong evidence that this is an
autoimmune disease and immunosuppressive therapy with cyclophosphamide and
corticosteroids efficiently relieves the symptoms and, prevents relapses. We report on four
cases of WG that presented with unusual features. The first patient presented with vague
joint pain, blackish discoloration of the skin and leg ulcers. The second patient presented as
fever of unknown origin and gingival hyperplasia. The third patient presented with hearing
loss while the fourth presented with arthritis, conjunctivitis and painful swelling of the ear.
It is emphasized that WG is a complex disease and can involve multiple organ systems.
Early recognition and institution of proper treatment are crucial for optimal outcome.
Key Words: Wegener’s Granulomatosis, leg ulcer, glomerulonephritis, proptosis, gingival
hyperplasia, sensorineural deafness, relapsing polychondritis, arthritis.

Introduction
Wegener’s Granulomatosis (WG) is a disorder characterized by necrotizing granulomatous
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vasculitis that primarily affects the upper and
lower respiratory tracts and the kidneys.1
Heinz Klinger first reported it in 1931, but it
the was not until 1936 that Wegener clearly
defined the clinicopathological spectrum of
the syndrome that now bears his name.2,3
Although the cause is unknown, there is strong
evidence that this is an autoimmune disease as
immunosuppressive therapy with cyclophosphamide and corticosteroids efficiently
relieves the symptoms and, prevents
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relapses.4 The presenting features of WG are
variable and diagnosis is based on the criteria
of the American College of Rheumatology
(ACR) published in 1990: nasal or oral
inflammation with painful or painless ulcers
or purulent bloody discharge; abnormal chest
radiography showing the presence of nodules,
fixed infiltrates, or cavities; urinary sediment
with microscopic hematuria (>5 RBCs per
high power field) or red cell casts in urinary
sediment; and granulomatous inflammation
on biopsy of an artery or in the perivascular
area. A patient who meets at least two of
these four criteria maybe diagnosed as
having “classic” WG.5 The sensitivity and
specificity of these criteria are 88% and 92%
respectively. “Limited” disease (without
glomerulonephritis) and unusual presentations can lead to delay in diagnosis and,
therefore, treatment. A consequence of delay
in diagnosis is that severe renal failure may
have developed before treatment is started.6
The prevalence of skin disease in WG has
been reported to be between 30 and 50%,
while musculoskeletal problems may
accompany the symptoms in 67% and earnose-and-throat (ENT) problems in 92% of
the patients.4 About 62% have oral mucosal
disease and ocular manifestations may be
seen in up to 50% of patients.
Wegener’s
Granulomatosis
is
an
uncommon, but not a rare disease, which
affects both sexes equally. It can occur at any
age, but most frequently presents in
adulthood. The mean age of onset in a
cohort of 158 patients reported by Hoffman
et al was 40 years.1
We present four cases of WG with unusual
clinical features. The presentation is followed
by discussion on the clinicopathologic
features and the role of antineutrophil
cytoplasmic antibody (ANCA) in the
diagnosis of WG.
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Case 1 - The non-healing leg ulcers
A 38-year-old seaman presented with vague
joint aches and pains as well as blackish
discoloration of the fingers and the toes, which
were thought to be vasculitic in nature. He
was treated with steroids for six months but
was lost to follow-up. He presented again
four years later with swollen ankle joints and
was labeled as having rheumatoid arthritis
without any investigations. He was again
treated with steroids followed by methotrexate
for about one year. Two years later, he developed blood stained nasal discharge; x-ray of
the paranasal sinuses was suggestive of
maxillary sinusitis and a biopsy revealed nonspecific acute and chronic inflammation. A
few weeks later, he developed ulcers on the
lateral aspect of his left leg and on the medial
aspect of the right leg. Biopsy of the ulcer
revealed chronic granulomatous inflammation
with extensive necrosis. A provisional diagnosis of cutaneous tuberculosis was made and
he received standard four drug anti-tuberculous
therapy (ATT) for nine months without any
improvement in the leg ulcers. Subsequently,
he developed hemoptysis, microscopic hematuria and proteinuria; the serum creatinine was
159 μmol/L and creatinine clearance was 40
ml/min. Renal biopsy showed pauci-immune
focal necrotizing glomerulonephritis as well
as vasculitic changes. Correlating the pathological and clinical findings, WG was considered
to be a likely possibility. The patient was
started on steroids and cyclophosphamide.
Following this, the leg ulcers healed, nasal
discharge and proteinuria disappeared and
renal function normalized. Cyclophosphamide
was changed to azathioprine after three
months.
Three years later, he stopped treatment and
subsequently presented with proptosis of the
right eye. Computerized tomographic (CT)
scan revealed a soft tissue enhancing mass in
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the right orbit pushing the eyeball anteriorly
and surrounding the optic nerve completely.
There was destruction of the medial wall with
extension into the paranasal sinuses. An
attempt was made to clear the mass, but was
unsuccessful. Biopsy revealed only fibrocollagenous tissue. Subsequently, he lost his
right eye. From renal point of view, he
continues to remain in remission on steroids
and azathioprine when last seen.

except slightly bulky kidneys. Soon after, the
patient developed acute oliguric renal
failure with BUN, creatinine and uric acid
rising to 52 mmol/L, 875 μmol/L and 660
μmol/L respectively. Repeat urinalysis
showed proteinuria and microscopic hematuria. He also had an episode of hemoptysis,
but the chest X-ray was normal. Bronchoscopy showed blood trickling out of the
posterior segment of the upper lobe.
Bronchial washings for AFB, fungal smear
and culture were negative. Bronchial biopsy
showed mild to moderate chronic inflammation
with no specific features or evidence of malignancy. Renal biopsy showed pauci-immune
crescentic nephritis with focal and segmental
necrotizing inflammation along with vasculitis
suggestive of WG. Thereafter, all medications
were discontinued and the patient was started
on pulse methylprednisolone followed by oral
steroids and oral cyclophosphamide. Cyclophosphamide was switched to azathioprine
after three months. He underwent few
sessions of hemodialysis till his renal function
normalized. Five years later, he continues to be
in remission with mild proteinuria and
normal renal function with serum creatinine
of 115 μmol/L. His body weight, when last
seen, was 77 kg.

Case 2 - Fever of unknown origin
A 53-year-old banker presented with one
week’s history of swollen gums, right cervical
lymphadenopathy and low grade fever. Chest
X-ray showed hazy apices. Fine needle
aspiration of the cervical lymph node showed
chronic granulomatous inflammation without
caseation. He was started on standard four
drug anti-tuberculous therapy (ATT). The
symptoms, however, persisted. Over the next
three weeks, several other antimicrobials were
also tried without any benefit. He subsequently
developed generalized weakness and significant
weight loss. It was around this time, about
four weeks after the onset of his symptoms,
that he presented to our institution.
At the time of presentation, he had a pulse of
108/min with blood pressure 100/60 mmHg
and temperature of 38°C. His body weight
was 30 kg. Right jugulodigastric lymph node
was palpable and his gums were swollen and
inflamed. Liver was palpable three cm below
the right costal margin. Laboratory investigations including complete blood count, liver
function tests and electrolytes were unremarkable; the blood urea nitrogen (BUN) was 6
mmol/L and creatinine was 80 μmol/L. Bone
marrow examination was also normal. Bone
marrow culture, smear and culture for acid
fast bacilli (AFB) were negative. Echocardiogram did not show any vegetations. A
CT scan of the chest and abdomen performed
at this time showed no significant abnormality

Case 3 - The lady with deafness
A 60-year-old lady presented with one
month’s history of fever, red eye, decreased
hearing, weight loss and vague ill health. On
examination she was febrile with a
temperature of 380C. Systemic examination
was unremarkable. Ophthalmologic examination
revealed uveitis. The blood tests showed a
mildly elevated leukocyte count of 11.1 x
109/L with an erythrocyte sedimentation rate
(ESR) of 122 mm/hr. All other investigations including urea, creatinine, electrolytes,
liver function tests (LFT), immune
electrophoresis and urinalysis were normal.
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Audiogram showed a mixed sensorineural
deafness in both ears, worse in the right ear.
Considering auto-immune deafness, she was
empirically started on steroids. Her deafness
improved dramatically and she was able to
hear perfectly well within a week of
treatment. About a month following initial
presentation, the patient developed loose
stools associated with fever. On this
occasion, the serum creatinine was found to
be 230 μmol/L. Urinalysis showed trace
proteins, microscopic hematuria and granular
casts. Renal biopsy showed pauciimmune
focal and segmental necrotizing glomerulonephritis. The cytoplasmic-ANCA (c-ANCA)
was also raised to 5.42 U/ml (normal is less
than 2). All these findings were consistent
with WG. The patient was put on cyclophosphamide in addition to steroids. Her
serum creatinine came down to 141 μmol/L
and has remained stable since then.
Case 4 - The swollen ear.
A 46-years-old male presented with two
weeks history of arthritis, painful red eyes and
fever. There was no history of diarrhea,
dysuria or sexual contact. On examination, he
was hemodynamically stable with temperature
of 38oC. The metacarpophalangeal joints of
both hands, both elbows, right shoulder and
both ankle joints were inflamed. Eye
examination revealed conjunctivitis, marginal
keratitis and scleritis. Systemic examination
was unremarkable. Laboratory investigations
revealed hemoglobin of 128 gm/L, ESR of
80mm/hr, C-reactive protein of 10.3 mg/dl
(normal 0 to1.0); antinuclear and anti-ds
DNA antibody and rheumatoid factor were
negative. The anti-streptolysin titer was within
normal range. The serum creatinine was 88
μmol/L, while urinalysis revealed microscopic
hematuria and trace proteinuria. A
provisional diagnosis of Rheumatoid arthritis
or Reiter’s disease was made and the patient
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was started on oral steroids, non-steroidal antiinflammatory drugs (NSAIDS), mesalazine
and broad spectrum intravenous antibiotics.
With NSAIDS, the arthritis improved and
the patient was discharged on mesalazine and
NSAIDS. Over the next three months, he had
another episode of arthritis involving the
large joints and was noted to have painful,
swollen and reddish discoloration of his ears.
At this time, a diagnosis of relapsing polychondritis was made; his renal function was
noted to be abnormal with serum creatinine
of 203 μmol/L. Urinalysis revealed 2+ proteinuria and microscopic hematuria. He was
referred to the nephrology service for further
evaluation. A 24-hours urine specimen revealed
protein excretion of 3.4 gm and a decreased
creatinine clearance of 36 ml/min. c-ANCA
was found to be very high at 84 U/ml
(Normal 0-2). Subsequently, a renal biopsy
was performed which revealed pauci-immune,
crescentic, necroticzing glomerulonephritis
consistent with WG. Over the next five
months, he received five cycles of pulse
methylprednisolone (1 gm/day for 3 days)
along with oral cyclophosphamide which
was changed to azathioprine after 12 weeks.
Six months after initiation of therapy he
remains symptom-free with a stable serum
creatinine of 106 μmol/L and creatinine
clearance of 68 ml/min. There was no
proteinuria.
Discussion
The mean and median period from the onset
of the symptoms to the diagnosis of WG were
4.7 and 15 months respectively in a study by
Hoffman et al.1 The second and third cases in
our report fall in this category. However, in
the first and second cases, early diagnosis was
hampered by a “misdiagnosis”. Other studies
have shown that although accurate diagnosis
was made within the first three months in
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42% of the patients, the disease, especially in
those without renal manifestations, followed
a confusing and indolent course of up to 16
years before a definitive diagnosis was established.7,8 In Pakistan, because of the high
prevalence of tuberculosis, a diagnosis of
tuberculosis is often made in patients with
signs and symptoms or histopathology of
“granulomatous disease”. It is imperative to
mention here that it has been proposed that
the clinical features of WG reflect a spectrum
of immune reactivity similar to that seen in
mycobacterial disease.9 In such a clinical/
immunological spectrum, the local chronic
inflammation in upper and lower airways
would reflect the tuberculoid end of the
disease, whereas vasculitis (in the kidney)
would reflect the lepromatous end of the
spectrum.6
The patient in Case-1 presented with cutaneous manifestations of WG. The prevalence
of skin disease has been reported to be
between 30% and 50%, and occasionally it
may be the initial sign of the disease.4,9-11 It
can continue for months and even years
before severe multi-organ system involvement develops.10
The lower extremities are the most common
location of the disease involved in 76% of the
cases.11 However, no single skin lesion is Pathognomic for WG. The dermatological manifestations observed by Frances et al in 35 of the 75
patients studied is shown in Figure 1. 7
Histologically, the cutaneous lesions can cover
a wide spectrum of findings. Leukocytoplastic
vasculitis was the most common type in the
study by Daoud et al11 and necrotizing vasculitis in the study by Frances et al.7 Though
previously described as a vasculitis of small
and medium sized arteries, results have led
researchers to conclude that all skin vessels
could be involved in the pathologic process
of WG.7 The prevalence of renal, occular and
central nervous system involvement is much
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Figure 1: Frequency of dermatologic manifestations
in 35 patients (Frances et al)7

higher in patients with specific cutaneous
involvement than in the other patients.11 In
the first patient, the disease manifested as
joint aches and nasal problems, and it is
known that musculoskeletal problems may
accompany the symptoms in 67% and ENT
problems in 92% of the patients.1 As is seen
in this case, it is not uncommon to label ENT
problems as allergy or infection. However, it
was not until hemoptysis developed that an
extensive evaluation, finally leading to a renal
biopsy, was performed. This correlation of
clinical and pathological findings resulted in
the diagnosis of WG.
In Case-2, the patient had gingival hyperplasia on presentation. In a study of 56 patients,
62% had oral mucosal disease with the commonest manifestation being oropharyngeal
ulcers in 60% patients and gingival symptoms
in 7%.13 In another study of 118 patients, the
most frequent manifestation of early or late
disease was buccal ulcer.12 Well-documented
reports for hyperplastic gingivitis can be
found.6,14,15 An unusual and distinctive gingivitis is considered pathognomic of WG in the
early stages and has been reported to occur in
many patients.16,17 It is characterized by an
exophytic hyperplasia with petechial flecks
and a red, friable, granular appearance.18 The
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gingivitis begins focally in the inter-dental
papillae and quickly spreads to produce segmental or panoral gingivitis, often accompanied by alveolar bone loss and tooth
mobility.16-19 Pain and bleeding are common.
Biopsy specimens generally show chronic,
non-specific inflammation with eosinophils
and histiocytes with diffuse foci of acute
inflammation containing polymorphonuclear
leukocytes and eosinophils, forming microabcesses in a few instances.14 Usually giant
cells are present,11,19 but vasculitis does not
occur.11,17,19 In the study by Patten et al, four
of the 40 patients (10%) had oral mucosal
disease but the characteristic gingivitis was
present in only one of the patients. However,
the presence of fever and a palpable lymph
node in this case led to a search for an
infection and, as already mentioned due to
high prevalence of tuberculosis in this part of
the world, anti-tuberculous therapy was
started. Since the fever was present in
conjunction with weight loss, a search was
also made for occult malignancy. Retrospectively, the presence of leukocytosis was not
a non-specific concomitant phenomenon. In
fact, neutrophils may have a primary role in
the pathogenesis, since antibody dependent
activation of granulocytes is being emphasized in recent studies. Patients with leukocytosis are therefore more likely to have more
aggressive and active disease.20 It was not
until the development of the acute renal
failure and the hemoptysis, that a renal biopsy
was considered and the patient was diagnosed
as WG.
Case-3 presented with sensorineural deafness
and uveitis, but the diagnosis was not clear till
the development of glomerulonephritis. The
ear is frequently involved early.12 Common
symptoms include ear ache, discharge and
deafness, which is present in some 15-30% of
patients and may be a presenting complaint in
as many as one fifth.4 Hearing loss is most
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commonly conductive but sensorineural
impairment may also occur.21 Sensorineural
deafness may be caused by a vasculitis affecting the vasa nervosum of the eighth nerve, the
internal auditory artery or its cochlear
branch.22,23 Fever due to WG was initially
present in 23% of the patients and led in all
cases to a search for secondary infection or,
when there was concomitant weight loss, for
an occult malignancy.1 In this case, given the
signs and symptoms, an autoimmune mechanism
was suspected and steroids were started
empirically with remarkable improvement.
This “autoimmune sensorineural hearing loss”
has been defined by otolaryngologists as “that
form of progressive sensorineural deafness
that responds to no treatment other than
immunosuppression”.24 A previous report has
documented the recovery of sensorineural
deafness after treatment with parentral steroids
to a patient, who probably had WG although
originally diagnosed as polyarteritis nodosa.23
However, in the patient in Case-3, an episode
of loose stool triggered the usual investigations and led to the discovery of a raised
creatinine which was previously normal and
the presence of microscopic hematuria. A
subsequent renal biopsy along with a raised cANCA helped to make the diagnosis of WG.
In case-1, during the course of the illness, the
patient also developed unilateral proptosis
with subsequent loss of the eye. Opthalmological manifestations including both ocular
and orbital diseases have been reported in 4050% of cases. The main lesion is a granulomatous
disease causing an inflammatory mass often
with proptosis and/or optic nerve compression
and small vessel vasculitis.25 Orbital granulomas can be characterized as contiguous, as
in this case, extending from nasal passages or
paranasal sinuses or, focal i.e., arising primarily in the orbit.26 The patient in case-3 had
uveitis, which has been attributed to small
vessel vasculitis, where as the patient in case-
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4 had keratitis and scleritis. The other manifestations of vasculitis in the eye include
conjunctivitis, episcleritis, optic nerve vasculitis,
retinitis, central retinal artery ischemia, or
cranial nerve palsies.
In case-4 the dominant feature at the time
of presentation was arthritis and eye
involvement. In the study by Fauci et al,4 joint
manifestations were seen in 67% and about
42% had non-deforming polyarthritis as seen
in our patient-4. Auricular chondritis has been
reported less commonly.27 Unilateral or
bilateral external ear inflammation is the most
common presenting feature of relapsing
polychondritis (RPC), seen in 43% initially
and in 83% eventually.28 In some patients,
RPC may be simultaneously present with
other connective tissue diseases. Whether
this association of RPC with other disorders
is coincidental, or represents a possible genetic
predisposition to the development of two
autoimmune diseases is presently unknown.29
Antineutrophil cytoplasmic antibody (ANCA),
first described in 1982 in patients with
systemic vasculitis and glomerulonephritis,
has emerged as a new diagnostic tool and
marker of disease activity for vasculitis.30,31
Two ANCA patterns may be seen with
indirect immunoflourescence of ethanol-fixed
neutrophils: a cytoplasmic pattern (c-ANCA)
and the artifactual perinuclear pattern (pANCA).32,33 The major antigen for c-ANCA
is proteinase 3, which is found within the
azurophil granules of the neutrophils.34 The
major antigen for p-ANCA is myeloperoxidase,
a lysosomal enzyme found in neutrophils .32
In classic WG, defined as granulomatous
inflammatory disease of the respiratory tract
and active glomerulonephritis, more than 90%
patients will have positive c-ANCA results.
In the absence of active renal disease (so
called “limited” Wegener’s granulomatosis),
the sensitivity of the c-ANCA test may be as
low as 65% to 70%.35 However, in Pakistan,

ANCA testing only became available in
1996. Therefore, c-ANCA values could not
be obtained in the first and second patient. cANCA levels were significantly raised in
case-3. For clinicians, c-ANCA serves as a
useful marker of WG in some patients and of
active disease in others.
Untreated, WG runs a rapidly fatal course,
with a mean survival of five months: more
than 90% of patients die within two years of
diagnosis12. The earlier studies showed that
with the use of corticosteroids, the average
time of survival improved to 12.5 months, but
the disease was usually fatal despite corticosteroid therapy.36 Fauci et al showed that with
continuous low dose oral cyclophosphamide
and prednisolone therapy, survival improved
markedly, with an 80% five year survival.
More than 90% of patients will experience
marked improvement and 75% will achieve
complete remission.4
Wegener’s Granulomatosis is a complex
disease, which can involve multiple organ
systems. Early recognition and institution of
appropriate treatment are critical for the
optimal outcome of this disease. Diagnosis
may be difficult, especially in early stages, in
the absence of the complete triad or in the
event of a clinical variant or unusual presentation.
It must therefore be borne in mind as a
differential when disease pathology is granulomatous in origin or if the disease remains
unresponsive to treatment. Clinical presentation
and laboratory evaluation provide adequate
clues but renal biopsy is often required for a
definitive diagnosis.
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